| Lightcalls.com |
|
|
![]() |
You're a woman. You're gaining weig...You're a woman. You're gaining weight in places you at no time gained weight before. And you just can't look to lose the excess encloses as easy as you used to join the club! You're united of the more than 47 million American women experiencing menopausal and pre-menopausal weight gain. (By the way, if you're through 35, "pre-menopausal" is you.) if it were not that Here's The Good News You don't have to direct the eye overweight, over-tired, and out-of-shape lust because your hormones, metabolism and caloric requirements are changing. Researchers are finally focusing their attention in succession menopausal and pre-menopausal weight gain (probably because they're getting older and on the outside of shape themselves). And what they're coming up with is a modern generation of diet pills' specifically discloseed to help menopausal and pre-menopausal women fail to win weight. New Discoveries Interestingly, the first of these new-generation diet pills (specifically unfolded to help overcome menopausal and pre-menopausal weight gain) is not a unsalable article it's a nutraceutical ... probably because nutraceutical works do not have to go on the lengthy FDA drug approval proces diet pill is called Estrin-D[TM],and in late studies, the active ingredients in Estrin-D were shown to increase resting metabolic rate in menopausal and pre-menopausal women automatically lessen caloric intake and provide sustained mechanical value But that's not all. Users reported that Estrin-D helped bridle mood swings, virtually eliminated overeating and gave them an overall faculty of perception of 'well being.' The First and solely "Diet Pill" for Menopausal and Pre-Menopausal Weight Loss While Estrin-D is the first and single "diet pill" specifically developed to help menopausal and pre-menopausal women forfeit weight, you can be certain it won't be the last. Society is changing. A of recent origin breed of over-35 women are no longer willing to just give up and become antique fat and tired. "In my mind a returns like Estrin-D was inevitable," said Dr Nathalie Chevreau, PhD RD Director of Women's Affairs for Basic Naturals[TM] Estrin-D's distributor. "There's a whole generation of women disclosed there who have outgrown Cosmopolitan magazine yet are not rely to join the AARP [American Association of Retired Persons] American women are refining age, beauty and sexuality, proving that life doesn't expiration at 40. It's about the way you're perceived, your ability to earn and be productive, and it's about the desire to stay healthy self-confident and happy. These women will not allow the MTV generation to push them aside." For greatest in number of or Us, Diet and Exercise Are Not Enough Dealing with menopausal and pre-menopausal weight gain has not been easy. For mostly of us, diet and exercise are not enough. We ne something more. Something to help with the hormonal and metabolic changes that begin in our mid-thirties. That's for what purpose this new emphasis on menopausal and pre-menopausal weight los is in like manner exciting. "Looking good, feeling young and being energetic are essential. This recent generation of diet pills targeting menopausal and pre-menopausal women has the ability to veraciously change lives," Dr. Chevreau says. "We're glad Estrin-D is the first and solitary 'diet pill' to address the emergencys of today's women:" Help Is Finally Here "This new-found attention to menopausal and pre-menopausal weight los has been a prolonged time in coming," continues Dr Chevreau. "Look at the market today: you have diet and manliness pills targeted to the under-30 generation (product like Zantrex[TM]-3[R] from Zoller[R] Labs), diet pills for the significantly overweight (Leptoprin[R] from A.G. Waterhouse[TM]), and fat blocker like Xenical[R] for the general population (from Hoffman LaRoche). nevertheless what about 'real' women? You would have conceit the menopausal and pre-menopausal weight los market, which makes up the majority of the female population, would have been addressed earlier. I gues it's better late than never" There's no way of telling to what degree many of the major put drugs into companies currently have menopause-specific diet pills going within the lengthy FDA approval proces yet with the size of the market and changing social inclines you can bet we'll be seeing more than a not many menopause-specific diet pills in the near time to come But for right now, if you're a woman athwart 35 and you're battling menopausal or pre-menopausal weight gain, there's solitary one: Estrin-D. Help is finally here! All trademarks are the exclusive right of their respective companies. * Zantrex[TM]-3[R] is a trademark exclusively licensed to Zoller[R] Laboratories, LLC ([dagger])Leproprin[R] is a trademark exclusively licensed to A.G, Waterhouse,[TM] LLC ** Xenical[R] is a registered trademark of HLR Technology Corporation. These statements have not been evaluated from the Food and Drug Administration. This result is not intended to diagnose, treat, restorative or prevent any disease. M Strobel is the editor of the web's most numerous popular diet site, www.MyFreeDiet.com. COPYRIGHT 2005 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |